KYORIN Holdings, Inc.
Status: Publicly traded
Direct answer
KYORIN Holdings, Inc. is publicly traded on JPX under the ticker 4569.T.
Based in Tokyo, Japan, and founded in 1923, KYORIN Holdings, Inc. is a pharmaceutical enterprise engaged in the discovery, development, production, and worldwide distribution of both innovative prescription drugs and generic equivalents. Its diverse therapeutic catalog features medications such as Flutiform for asthma; Desalex, an antiallergic agent; and treatments like Beova, Uritos, and Imidafenacin KYORIN for...
Can you invest in KYORIN Holdings, Inc.?
Yes. KYORIN Holdings, Inc. is publicly traded on JPX under the ticker 4569.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for KYORIN Holdings, Inc.
Detailed equity research is provided by MarketSnap.